IndiGo Chairman Addresses Recent Operational Disruptions
Vikram Singh Mehta, Chairman of IndiGo, addressed the recent operational disruptions that caused flight cancellations and passenger delays on…
Biocon S&P Global Revises Biocon Biologics Outlook to Positive
S&P Global Ratings has revised the credit rating outlook for Biocon Biologics to Positive, acknowledging the company’s progress in…
MMTC Ltd Clarification on Unusual Stock Volume Activity
MMTC Ltd. has addressed recent queries regarding unusual stock volume activity. In a communication dated December 11, 2025, the company stated…
Power Finance Corporation Subsidiary Incorporates LATUR REZ Transmission Limited
Power Finance Corporation (PFC) announced the incorporation of LATUR REZ Transmission Limited as a wholly-owned subsidiary of PFC Consulting…
Aditya Birla Fashion Receives Demand Order from Kanpur Corporate Circle
Aditya Birla Fashion and Retail Limited (ABFRL) has received a demand order dated December 9, 2025, from the Joint Commissioner, Corporate…
IRB Infrastructure Developers Credit Ratings Reaffirmed by CRISIL
CRISIL Ratings has reaffirmed IRB Infrastructure Developers’ CRISIL AA-/Stable rating for long-term bank facilities and CRISIL A1+…
IIFL Finance Issuance of Non-Convertible Debentures on Private Placement Basis
IIFL Finance has announced the issuance of senior, unsecured, listed, rated, redeemable Non-Convertible Debentures (NCDs) through private…
Karur Vysya Bank Credit Rating on Deposit Programme Reaffirmed
Karur Vysya Bank (KVB) has announced that its credit rating for the Certificate of Deposit Programme has been reaffirmed by ICRA. The rating…
IndiGo Operational Update Shows Network Stabilizing After Adjustments
IndiGo announced that its network has fully stabilized following recent adjustments, with all destinations connected since December 8th, 2025.…
Alembic Pharmaceuticals Receives USFDA Approval for Loteprednol Etabonate Suspension
Alembic Pharmaceuticals has received USFDA final approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%. This…